Valsts: Īrija
Valoda: angļu
Klimata pārmaiņas: HPRA (Health Products Regulatory Authority)
CICLOSPORIN
Teva Pharma B.V.
L04AD01
CICLOSPORIN
100 Milligram
Capsules, Soft
Product subject to prescription which may be renewed (B)
Calcineurin inhibitors
Authorised
2013-08-23
1 PACKAGE LEAFLET PACKAGE LEAFLET: INFORMATION FOR THE USER VANQUORAL 10 MG CAPSULES, SOFT VANQUORAL 25 MG CAPSULES, SOFT VANQUORAL 50 MG CAPSULES, SOFT VANQUORAL 100 MG CAPSULES, SOFT CICLOSPORIN READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4 WHAT IS IN THIS LEAFLET: 1. What Vanquoral is and what it is used for 2. What you need to know before you take Vanquoral 3. How to take Vanquoral 4. Possible side effects 5. How to store Vanquoral 6. Contents of the pack and other information 1. WHAT VANQUORAL IS AND WHAT IT IS USED FOR WHAT VANQUORAL IS The name of your medicine is Vanquoral. It contains the active substance ciclosporin. This belongs to a group of medicines known as immunosuppressive agents. These medicines are used to lower the body’s immune reactions. WHAT VANQUORAL IS USED FOR AND HOW VANQUORAL WORKS IF YOU HAVE HAD AN ORGAN TRANSPLANT, BONE MARROW AND STEM CELL TRANSPLANTATION, the function of Vanquoral is to control your body’s immune system. Vanquoral prevents rejection of transplanted organs by blocking the development of certain cells which would normally attack the transplanted tissue. IF YOU HAVE AN AUTOIMMUNE DISEASE, in which your body’s immune response attacks your body’s own cells, Vanq Izlasiet visu dokumentu
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Vanquoral 100 mg Capsules, soft 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each soft capsule contains 100 mg ciclosporin. Excipient(s) with known effect: Each 100 mg soft capsule contains approximately 160 mg of anhydrous ethanol, 28.83 mg 70% sorbitol and 434.00 mg macrogolglycerol hydroxystearate. For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Capsule, soft. Opaque brown soft gelatin capsules (Oblong 20, approx. 24.7 x 9.9 mm) containing colourless to slightly yellowish oily liquid, with printing the IVAX “hourglass” logo “100 mg”. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Transplantation indications _Solid organ transplantation_ Prevention of graft rejection following solid organ transplantation. Treatment of transplant cellular rejection in patients previously receiving other immunosuppressive agents. _Bone marrow transplantation_ Prevention of graft rejection following allogeneic bone marrow and stem cell transplantation. Prevention or treatment of graft-versus-host disease (GVHD). Non-transplantation indications _Endogenous uveitis_ Treatment of sight-threatening intermediate or posterior uveitis of non-infectious aetiology in patients in whom conventional therapy has failed or caused unacceptable side effects. Treatment of Behçet uveitis with repeated inflammatory attacks involving the retina in patients without neurological manifestations. _Nephrotic syndrome_ Steroid-dependent and steroid-resistant nephrotic syndrome, due to primary glomerular diseases such as minimal change nephropathy, focal and segmental glomerulosclerosis, or membranous glomerulonephritis. Vanquoral can be used to induce and maintain remissions. It can also be used to maintain steroid-induced remission, allowing withdrawal of s Izlasiet visu dokumentu